The company said net revenues for the 3-month period ended March 31, 2024 rose 10.8%, or $376 million, to $3.844 billion. Income before income taxes increased $122 million, or 57%, to $336 million.

10-QQuarterly reportFiled May 8, 2024Period of report Mar 31, 2024Summary published (UTC) Oct 24, 2026

Key points

AI summary

The company said net revenues for the 3-month period ended March 31, 2024 rose 10.8%, or $376 million, to $3.844 billion. Income before income taxes increased $122 million, or 57%, to $336 million.
The company said net revenues from its acute care hospital services on a Same Facility basis rose $185 million, or 9.6%, and income before income taxes increased $65 million, or 45%, to $207 million. The figures include about $38 million in net reimbursements under the Nevada state directed payment program.
UHS said it recorded a significant increase in hospital-based physician-related expenses in its acute care segment, especially in emergency room care and anesthesiology, and said these expenses could continue to have an unfavorable material impact on its results of operations for the foreseeable future. It also said it is experiencing inflationary pressures, primarily in personnel costs.
The company said that as of March 31, 2024, it had $733 million of available borrowing capacity under its $1.2 billion revolving credit facility and that the outstanding balance of its tranche A term loan was $2.23 billion. Its debt-to-total-capitalization ratio was about 44%.

Key figures

Quarter ended March 31, 2024

Revenue: $3.8B
Operating income: $389M
Net income: $262M
EPS: $3.82
Operating cash flow: $396M

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q1 2024 Net Revenues and Income Before Income Taxes

The company said net revenues for the 3-month period ended March 31, 2024 rose 10.8%, or $376 million, to $3.844 billion. Income before income taxes increased $122 million, or 57%, to $336 million.

Source · Based on the MD&A text of the filing

Same Facility Acute Care Hospital Services Results

The company said net revenues from its acute care hospital services on a Same Facility basis rose $185 million, or 9.6%, and income before income taxes increased $65 million, or 45%, to $207 million. The figures include about $38 million in net reimbursements under the Nevada state directed payment program.

Source · Based on the MD&A text of the filing

Inflationary Pressures and Physician-Related Expenses

UHS said it recorded a significant increase in hospital-based physician-related expenses in its acute care segment, especially in emergency room care and anesthesiology, and said these expenses could continue to have an unfavorable material impact on its results of operations for the foreseeable future. It also said it is experiencing inflationary pressures, primarily in personnel costs.

Source · Based on the MD&A text of the filing

Borrowings and Liquidity as of March 31, 2024

The company said that as of March 31, 2024, it had $733 million of available borrowing capacity under its $1.2 billion revolving credit facility and that the outstanding balance of its tranche A term loan was $2.23 billion. Its debt-to-total-capitalization ratio was about 44%.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗